IL6 and head and neck squamous cell carcinoma: Patients with HNSCC also exhibited elevated levels of IL-6 (37 ± 14.9 pg/mL) compared to healthy controls (2.8 ± 1.5 pg/mL); the difference was highly statistically significant (p < 0.0001).